Portfolio Companies 2026 for Bain Capital Life Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Bain Capital Life Sciences accounts for 33 tracked companies with verified cap-table data, 33 of which disclose round sizes totalling $11B. The median disclosed raise is $180M, and the largest is Kymera Therapeutics at $3B, ahead of Kailera Therapeutics ($1.6B) and Imperative Care ($595M).
The names that recur most often on these portfolio cap tables are Bain Capital Life Sciences (33 companies), RA Capital Management (8 companies), Redmile Group (7 companies), BlackRock (5 companies), Janus Henderson Investors (4 companies), Rock Springs Capital (4 companies). By latest disclosed round, the market skews Series A (12), Series C (7), Series B (5), Series D (3).
Companies tracked: 33
Disclosed funding total: $11B across 33 companies
Median disclosed raise: $180M
Largest raise: Kymera Therapeutics — $3B
Stage mix: Series A 12 · Series C 7 · Series B 5 · Series D 3
